Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three drugs plus zidovudine for prevention of infections in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED